Zadnji put ažurirano :
19/11/2024
istraživačkih timova - Genentech, Inc   pdf  
S A D
Farmaceutski laboratorij
Genentech, Inc
San Francisco
Bibliografija   Bibliografija   (5)  
1
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. (zheng.kai@gene.com)
Int J Pharm Compound - 2021 - ;25,3:246-257
2
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. (sreedhaa@gene.com))
J Pharm Sci - 2012 - ; DOI 10.1002 / jps.23403
3
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. (lentz.yvonne@gene.com)
AAPS Pharm Sci - 2011 - ; 15, 2 : 264-272.
4
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. ()
Hemodial Int - 2011 - ; 15, 2 : 364-272.
5
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1904-1909.

Liste   molekule studirao   (13)  
trombolitički injekcija Alteplase
lijek protiv karcinoma injekcija Atezolizumab
kardiotonici injekcija Dobutamine hydrochloride
kardiotonici injekcija Dopamine hydrochloride
antikoagulant injekcija Heparin sodium
lokalna anestezija injekcija Lidocaine hydrochloride
antiritmičan injekcija Metoprolol tartrate
analgetik injekcija Morphine sulfate
vazodilatator injekcija Nitroglycerin
lijek protiv karcinoma injekcija Pertuzumab
betablokatori injekcija Propranolol hydrochloride
trombolitički injekcija Tenecteplase
lijek protiv karcinoma injekcija Trastuzumab

  Mentions Légales